NRX Pharmaceuticals Inc. has appointed Joseph M. Casper as Chief Operating Officer, effective January 27, 2026. Casper brings 35 years of experience in the healthcare industry, including leadership roles at Deloitte, First Consulting Group, Kaiser Permanente, and Anthem. He has also served on the boards of several healthcare and technology organizations and most recently was Chief Strategy Officer at Ryte AI.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRX Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-002682), on February 02, 2026, and is solely responsible for the information contained therein.